A review of deubiquitinases and thier roles in tumorigenesis and development
Xian-Wen Liang,Sheng-Zhong Wang,Bing Liu,Jia-Cheng Chen,Zhi Cao,Feng-Ran Chu,Xiong Lin,Hui Liu,Jin-Cai Wu
DOI: https://doi.org/10.3389/fbioe.2023.1204472
IF: 5.7
2023-05-12
Frontiers in Bioengineering and Biotechnology
Abstract:Ubiquitin is a small protein that can be added onto target protein for inducing target degradation, thereby modulating the activity and stability of protein. Relatively, deubiquitinases (DUBs), a class catalase that can remove ubiquitin from substrate protein, provide a positive regulation of the protein amount at transcription level, post-translational modification, protein interaction, etc. The reversible and dynamic ubiquitination-deubiquitination process plays an essential role in maintaining protein homeostasis, which is critical to almost all the biological processes. Therefore, the metabolic dysregulation of deubiquitinases often lead to serious consequences, including the growth and metastasis of tumors. Accordingly, deubiquitinases can be served as key drug targets for the treatment of tumors. The small molecule inhibitors targeting deubiquitinases has become one of the hot spots of anti-tumor drug research areas. This review concentrated on the function and mechanism of deubiquitinase system in the proliferation, apoptosis, metastasis and autophagy of tumor cells. The research status of small molecule inhibitors of specific deubiquitinases in tumor treatment is introduced, aiming to provide reference for the development of clinical targeted drugs.
multidisciplinary sciences